My Cart

Integrin alpha 3 beta 1

Integrin alpha 3 beta 1 Overview

English NameIntegrin alpha 3/beta 1Approved Drugs0
Drugs in Clinical Trials1Target Synonym
Highest Development StagePhase 1 Clinical
English NameIntegrin alpha 3/beta 1
Target Synonym
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 1 Clinical

Integrin alpha 3 beta 1 Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Human (1)Rat (1)Cynomolgus (1)

  • Tag

    His Tag (3)

  • Conjugate

    Unconjugated (3)

Integrin alpha 3 beta 1 Background

Integrin alpha-3/beta-1 is a receptor for fibronectin, laminin, collagen, epiligrin, thrombospondin and CSPG4. Integrin alpha-3/beta-1 provides a docking site for FAP (seprase) at invadopodia plasma membranes in a collagen-dependent manner and hence may participate in the adhesion, formation of invadopodia and matrix degradation processes, promoting cell invasion. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
VAX-014VAX-014Phase 1 ClinicalVaxiion Therapeutics LlcSolid tumours
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland